Form 4: Ardent Health Partners Executive Reports Stock Transactions
SEC Form 4
David Raynor Byers, SVP & Chief Accounting Officer of Ardent Health Partners, reports the acquisition and disposal of company stock.
Summary
- David Raynor Byers, SVP & Chief Accounting Officer of Ardent Health Partners, filed a Form 4 detailing changes in beneficial ownership of the company's stock.
- On March 31, 2025, 676 shares of common stock were disposed of at a price of $13.75 per share to cover tax obligations related to vesting restricted stock units.
- On April 1, 2025, Byers acquired 11,565 restricted stock units at a price of $0.
- Following these transactions, Byers directly owns 112,315 shares of Ardent Health Partners common stock.
Sentiment
Score: 6
Explanation: The document reflects routine transactions related to executive compensation. It's neutral in sentiment as it simply reports required information.
Positives
- The acquisition of 11,565 restricted stock units indicates continued alignment of the executive's interests with the company's long-term performance.
Future Outlook
The restricted stock units vest in three substantially equal installments on each anniversary of April 1, 2025, subject to continued service with the Issuer.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the trading activities of company insiders. These filings are closely watched by investors seeking insights into management's perspective on the company's stock.
Comparison to Industry Standards
- Executive compensation packages often include restricted stock units to align management's interests with shareholders.
- The vesting schedule of three years is a common practice in the industry.
- Tax withholding practices upon vesting of restricted stock units are standard procedure.
Stakeholder Impact
- Shareholders are informed about the stock transactions of a key executive, providing transparency.
Key Dates
| Date | Description |
|---|---|
| 03/31/2025 | Disposal of 676 shares of common stock for tax obligations. |
| 04/01/2025 | Acquisition of 11,565 restricted stock units. |
| 04/01/2025 | First vesting date for restricted stock units, with subsequent vesting annually. |
| 04/02/2025 | Date of signature by Attorney-in-Fact. |
Keywords
Form 4, Ardent Health Partners, Stock Transactions, Beneficial Ownership, Executive Compensation, Restricted Stock Units, Byers, ARDT
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.